PMAIP1 and non-small cell lung carcinoma: In addition, we used CRISPR/Cas9 gene editing to create stable knockout (KO) of PMAIP1 (NOXA) in three TP53mutant NSCLC cell lines including H23, HCC827 and PC9 (Fig. 3K).